Schneider Downs Wealth Management Advisors, LP Pfizer Inc Transaction History

Schneider Downs Wealth Management Advisors, LP

$478 Million
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$25.89 - $29.73 $216,543 - $248,661	8,364 New	8,364 $232,000
Q3 2022 Oct 26, 2022	SELL	$43.76 - $53.42 $116,620 - $142,364	-2,665 Reduced 20.29%	10,469 $458,000
Q2 2022 Jul 13, 2022	BUY	$46.53 - $55.17 $129,120 - $153,096	2,775 Added 26.79%	13,134 $689,000
Q1 2022 May 02, 2022	SELL	$45.75 - $56.69 $38,201 - $47,336	-835 Reduced 7.46%	10,359 $536,000
Q4 2021 Jan 31, 2022	SELL	$41.32 - $61.25 $5,660 - $8,391	-137 Reduced 1.21%	11,194 $661,000
Q3 2021 Oct 14, 2021	BUY	$39.25 - $50.42 $86,821 - $111,529	2,212 Added 24.26%	11,331 $487,000
Q2 2021 Jul 20, 2021	BUY	$35.91 - $40.68 $5,422 - $6,142	151 Added 1.68%	9,119 $357,000
Q1 2021 Apr 26, 2021	BUY	$33.49 - $37.77 $300,338 - $338,721	8,968 New	8,968 $325,000
Q4 2020 Jan 21, 2021	SELL	$33.47 - $42.56 $270,370 - $343,799	-8,078 Closed	0 $0
Q3 2020 Oct 14, 2020	BUY	$31.75 - $37.25 $256,476 - $300,905	8,078 New	8,078 $296,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$13.7 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.3 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$7.67 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.44 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

117M
Shares

$3.13 Billion
0.63% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schneider Downs Wealth Management Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Schneider Downs Wealth Management Advisors, LP with notifications on news.

Account